FDA clears advanced smartwatch capable of detecting AFib

Anthony Vecchione | | Cardiovascular Business | Heart Rhythm
Withings watch

Withings, an international healthcare technology company, has received FDA clearance for ScanWatch, its wearable solution that can track a person's heart rate, identify signs of atrial fibrillation (AFib) and more. 

ScanWatch will be available in North America in November. It was launched in Europe in 2020. 

"ScanWatch has been clinically validated to detect AFib and can aid in the detection of breathing disturbances at night, that can be signs of sleep apnea. " Mathieu Letombe, CEO of Withings, said in a press release. "It is our most ambitious medical watch to date and has the potential to benefit millions of people."

The company said that ScanWatch can identify signs of AFib due to its ability to take a medical-grade ECGs. The solution was also designed to notify a patient of potential heart events.

ScanWatch can also be used to monitor blood oxygen levels and to detect if a patient is having difficulty breathing, the company added. 

Anthony Vecchione

Related Content

FDA announces recall of cryoablation catheters after multiple injuries, including 4 deaths
Cardiologists perform world’s first leadless LBBAP procedures with Abbott pacemaker
President of medical device company resigns over conduct allegations after 7 months in role
FDA and Boston Scientific issue urgent alert about pacemaker failures following 2 deaths
Treating AFib patients with TAVR still linked to elevated risks
Cardiologists work to standardize the diagnosis and management of acute myocarditis

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.